Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials for Ra Pharmaceuticals
Explore 38 clinical trials worldwide
Search
Showing 1-38 of 38 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Sponsor: Ra Pharmaceuticals
Clinical Trials (38)
NCT07104032
Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
PHASE3
Not yet recruiting
132 participants
Started: Nov 30, 2025 · Completed: Dec 31, 2029
1 condition
2 sponsors
0 locations
NCT07158411
Evaluate the Effect of Vimseltinib on Organic Cation Transporter 2 (OCT2)
PHASE1
Not yet recruiting
20 participants
Started: Nov 30, 2025 · Completed: Jun 30, 2026
1 condition
1 sponsor
0 locations
NCT07214844
A Prospective Study to Evaluate the Efficacy of Iovera Lumbar Medial Branch Cryoneurolysis Versus Radiofrequency Ablation for the Treatment of Chronic Low Back Pain
NA
Not yet recruiting
110 participants
Started: Nov 30, 2025 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT07212114
Efficacy of EXPAREL vs. Bupivacaine
PHASE3
Not yet recruiting
104 participants
Started: Oct 31, 2025 · Completed: Aug 31, 2029
2 conditions
2 sponsors
1 location
NCT07158398
Evaluate the Effect of Vimseltinib on the Pharmacokinetics of a BCRP and OATP1B1 Substrate
PHASE1
Recruiting
20 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT07075471
Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib
N/A
Recruiting
100 participants
Started: Aug 31, 2025 · Completed: Sep 30, 2027
1 condition
1 sponsor
1 location
NCT06628947
A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa
PHASE2
Recruiting
36 participants
Started: Aug 29, 2025 · Completed: Aug 31, 2027
1 condition
1 sponsor
5 locations
NCT06966024
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
PHASE1
Recruiting
60 participants
Started: Aug 27, 2025 · Completed: Feb 28, 2029
3 conditions
1 sponsor
2 locations
NCT06946368
Effectiveness of Exparel Anesthetic Administered by the Surgeon During Knee Surgery
NA
Recruiting
60 participants
Started: Aug 18, 2025 · Completed: Dec 11, 2026
1 condition
2 sponsors
1 location
NCT07125833
Cryoneurolysis of the Suprascapular Nerve for Perioperative Pain Control After Receiving a Reverse Total Shoulder Arthroplasty (RTSA)
NA
Recruiting
20 participants
Started: Jul 30, 2025 · Completed: Aug 31, 2026
1 condition
2 sponsors
1 location
NCT06977568
A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip
PHASE2
Recruiting
32 participants
Started: Jul 25, 2025 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT06935539
Cryoneurolysis vs Radiofrequency Ablation for Chronic Sacroiliac Joint Pain
NA
Not yet recruiting
30 participants
Started: May 31, 2025 · Completed: Aug 31, 2026
1 condition
2 sponsors
0 locations
NCT06958289
Cryoneurolysis for Spasticity Treatment: Long-term Clinical Outcomes and Mechanisms in the Central Nervous System
NA
Not yet recruiting
25 participants
Started: May 1, 2025 · Completed: May 1, 2028
1 condition
2 sponsors
1 location
NCT06825702
Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema
PHASE2
Recruiting
28 participants
Started: May 1, 2025 · Completed: Dec 31, 2026
1 condition
1 sponsor
4 locations
NCT06884865
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee
PHASE2
Recruiting
135 participants
Started: Feb 26, 2025 · Completed: Mar 31, 2032
1 condition
1 sponsor
17 locations
NCT06630234
A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)
PHASE1/PHASE2
Recruiting
120 participants
Started: Dec 10, 2024 · Completed: May 31, 2028
1 condition
1 sponsor
10 locations
NCT06619561
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
PHASE2
Recruiting
48 participants
Started: Nov 21, 2024 · Completed: Oct 31, 2029
1 condition
1 sponsor
23 locations
NCT06713135
A Study on Safety and Effectiveness of Long-term Treatment With Vamorolone in Boys With Duchenne Muscular Dystrophy
PHASE4
Recruiting
80 participants
Started: Nov 10, 2024 · Completed: Sep 30, 2028
1 condition
1 sponsor
12 locations
NCT06619275
Ripretinib (QINLOCK®) According to Current SmPC
N/A
Recruiting
100 participants
Started: Oct 17, 2024 · Completed: Nov 30, 2027
1 condition
2 sponsors
1 location
NCT06603051
The Effect of Pre-Operative Cryoneurolysis on Post-Operative Narcotic Consumption in Patients Undergoing Autograft ACL Reconstruction
NA
Recruiting
20 participants
Started: Aug 28, 2024 · Completed: Feb 28, 2026
1 condition
2 sponsors
2 locations
NCT06287463
Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway
PHASE1/PHASE2
Active, not recruiting
140 participants
Started: May 14, 2024 · Completed: Aug 31, 2027
10 conditions
1 sponsor
9 locations
NCT06350981
Analgesic Requirement for Post-Operative Pain Control in TLIP Interbody Fusion
PHASE2/PHASE3
Enrolling by invitation
76 participants
Started: Apr 30, 2024 · Completed: Mar 1, 2026
5 conditions
2 sponsors
1 location
NCT06340451
Study to Assess the Efficacy and Safety of Iovera®° System in Subjects With Upper Extremity Spasticity
PHASE3
Recruiting
132 participants
Started: Apr 16, 2024 · Completed: Mar 31, 2026
1 condition
1 sponsor
18 locations
NCT06271265
Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery
PHASE1
Recruiting
48 participants
Started: Mar 29, 2024 · Completed: Jan 31, 2027
1 condition
1 sponsor
4 locations
NCT06269705
ZILRETTA in Subjects With Shoulder Osteoarthritis
PHASE3
Recruiting
250 participants
Started: Feb 5, 2024 · Completed: Aug 31, 2025
1 condition
1 sponsor
32 locations
NCT06077422
Exparel vs. Marcaine ESP Block for Post-cardiac Surgical Pain
PHASE2/PHASE3
Recruiting
120 participants
Started: Jan 11, 2024 · Completed: Apr 5, 2025
4 conditions
2 sponsors
1 location
NCT05734105
A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib
PHASE3
Recruiting
54 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2027
1 condition
1 sponsor
70 locations
NCT05957367
A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
PHASE1/PHASE2
Recruiting
94 participants
Started: Sep 28, 2023 · Completed: Mar 31, 2029
1 condition
1 sponsor
10 locations
NCT05282953
A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS)
PHASE1/PHASE2
Recruiting
12 participants
Started: Nov 10, 2022 · Completed: Jul 31, 2026
2 conditions
1 sponsor
2 locations
NCT05059262
Study of Vimseltinib for Tenosynovial Giant Cell Tumor
PHASE3
Active, not recruiting
123 participants
Started: Oct 14, 2021 · Completed: Jul 31, 2026
5 conditions
1 sponsor
35 locations
NCT05495334
Innovations in Genicular Outcomes Registry
N/A
Recruiting
4,000 participants
Started: Sep 23, 2021 · Completed: Jun 30, 2027
1 condition
1 sponsor
14 locations
NCT04892017
A Phase 1/2 Study of Inlexisertib (DCC-3116) in Patients With RAS/MAPK Pathway Mutant Solid Tumors
PHASE1/PHASE2
Active, not recruiting
144 participants
Started: Jun 15, 2021 · Completed: Aug 31, 2028
3 conditions
1 sponsor
10 locations
NCT04119687
Study to Evaluate the Safety and Tolerability of FX201 in Patients with Osteoarthritis of the Knee
PHASE1
Active, not recruiting
72 participants
Started: Mar 2, 2020 · Completed: Nov 28, 2026
1 condition
1 sponsor
6 locations
NCT04126876
A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma
PHASE2
Recruiting
214 participants
Started: Jan 22, 2020 · Completed: Nov 1, 2031
1 condition
2 sponsors
1 location
NCT03739021
Exparel for Total Shoulder Pain
PHASE2/PHASE3
Not yet recruiting
60 participants
Started: Nov 30, 2019 · Completed: Nov 15, 2020
1 condition
2 sponsors
0 locations
NCT03865082
Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)
PHASE2
Active, not recruiting
30 participants
Started: Oct 29, 2019 · Completed: Apr 30, 2022
1 condition
2 sponsors
3 locations
NCT03673501
A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib
PHASE3
Active, not recruiting
453 participants
Started: Feb 8, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
121 locations
NCT03069469
Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
PHASE1/PHASE2
Active, not recruiting
120 participants
Started: Feb 16, 2017 · Completed: Aug 31, 2028
5 conditions
1 sponsor
24 locations